Copyright
©The Author(s) 2025.
World J Virol. Mar 25, 2025; 14(1): 99249
Published online Mar 25, 2025. doi: 10.5501/wjv.v14.i1.99249
Published online Mar 25, 2025. doi: 10.5501/wjv.v14.i1.99249
Pathogen | Location | Clinical features | Diagnosis | Chemoprophylaxis | Treatment |
Cytomegalovirus | Gastric, small bowel (ileum), and large bowel (colon) | Bloody diarrhea, fever, weight loss, fever, anorexia, abdominal pain | DNA PCR from stool sample | None recommended | IV ganciclovir for 21 to 42 days (can with to oral valganciclovir once the patient can tolerate) |
Herpes simplex | Anorectal | Tenesmus, rectal pain, hematochezia, proctitis | DNA PCR for cutaneous lesion | None recommended | Acyclovir/Valacyclovir PO for 5 to 10 days |
Cryptosporidium | Gastric, small bowel (ileum), and large bowel | Acute/Subacute onset watery diarrhea, nausea/vomiting, lower abdominal cramping | Microscopic identification of the oocysts in stool with acid-fast staining or direct immunofluorescence | None recommended | Nitazoxanide (500/1000 mg POD BID for 14 days) or paromomycin (500 mg PO QID for 14 to 21 days) |
Microsporidia | Small and large bowel | Diarrhea with cramps and abdominal pain, wasting, malnutrition | Microscopic identification of the spores in stool with trichrome staining | None recommended | For Enterocytozoon bieneusi–nitazoxanide 500 mg BID for 14 days. For intestinal infection caused by microsporidia other than E. bieneusi–albendazole 400 mg BID for 14 days |
Isospora belli | Gastric | Watery diarrhea, with abdominal pain, cramping, nausea/vomiting, low-grade fever, dehydration | Microscopic identification of the oocysts in stool with acid-fast staining or UV fluorescence microscopy | None recommended. Indirect evidence of a protective effect of TMP-SMX | TMP-SMX (160/800mg QID for 10 days) |
Cyclospora | Small bowel | Watery diarrhea, weight loss, abdominal cramping, low-grade fever | Microscopic identification of the oocysts in stool with acid-fast staining | None recommended | TMP-SMX (160/800 mg PO BID for 14 days) or nitazoxanide (500 mg PO BID for 7 days) |
Entamoeba histolytica | Colon | Diarrhea with blood and mucus, cramping lower abdomen pain, bloating, fever, chills | DNA PCR from stool sample, stool antigen test, microscopic identification of the cysts/trophozoites in stool | None recommended | Metronidazole 500-750 mg PO TID for 5-10 days or tinidazole 2 g PO once daily for 3 days, followed by a luminal agent |
Histoplasmosis | Terminal ileum and colon | Intermittent bloody diarrhea, abdominal pain, fever, weight loss | EIA for urine or serum antigen. Histopathological examination using GMS stain | Itraconazole for patients with CD4 counts < 150/mm3 | IV liposomal amphotericin B (3 mg/kg daily) for ≥ 2 weeks or clinical improvement with stepdown to oral itraconazole |
Mycobacterium tuberculosis | Terminal ileum and cecum | Abdominal pain, diarrhea, fever, weight loss, night sweats, fatigue | Acid-fast staining | None recommended | Initial phase (2 months): Isoniazid 300 mg daily, rifampin 600 mg daily, pyrazinamide 25 mg/kg daily, and ethambutol 15 mg/kg daily. Continuation phase (4-7 months): Isoniazid 300 mg daily and rifampin 600 mg daily |
Mycobacterium avium complex | Small bowel and large bowel | Fever, abdominal pain, weight loss, night sweats, fatigue | Acid-fast staining | Azithromycin for patients with CD4 count < 50/mm3 | Clarithromycin (7.5 to 15 mg/kg PO BID for at least 12 months) |
- Citation: Moliya P, Singh A, Singh N, Kumar V, Sohal A. Insights into gastrointestinal manifestation of human immunodeficiency virus: A narrative review. World J Virol 2025; 14(1): 99249
- URL: https://www.wjgnet.com/2220-3249/full/v14/i1/99249.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i1.99249